Stockholm - Delayed Quote SEK

CHOSA Oncology AB (CHOSA.ST)

0.5850
-0.0300
(-4.88%)
At close: June 13 at 5:29:30 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
9,714
9,714
23,512
1,167
61,856.7040
Operating Income
-9,714
-9,714
-23,512
-1,167
-61,856.7040
Net Non Operating Interest Income Expense
-17.4170
-17.4170
-512.6460
0
-204.0620
Pretax Income
-9,594
-9,594
-23,752
-1,167
-62,076.5550
Tax Provision
0
0
191
-146
-7,502.5280
Net Income Common Stockholders
-9,594
-9,594
-23,943
-1,021
-54,574.0270
Diluted NI Available to Com Stockholders
-9,594
-9,594
-23,943
-1,021
-54,574.0270
Basic EPS
-0.13
--
-0.35
-0.05
-2.69
Diluted EPS
-0.13
--
-0.35
-0.05
-2.69
Basic Average Shares
75,710.1280
--
66,178.8370
20,320.7330
20,320.7330
Diluted Average Shares
75,710.1280
--
66,178.8370
20,320.7330
20,320.7330
Total Operating Income as Reported
-9,714
-9,714
-23,512
-1,167
-61,856.7040
Total Expenses
9,714
9,714
23,512
1,167
61,856.7040
Net Income from Continuing & Discontinued Operation
-9,594
-9,594
-23,943
-1,021
-54,574.0270
Normalized Income
-9,594
-9,594
-23,943
-1,021
-54,574.0270
Interest Income
5.1990
5.1990
1.9260
0
0
Interest Expense
22.6160
22.6160
514.5720
0
204.0620
Net Interest Income
-17.4170
-17.4170
-512.6460
0
-204.0620
EBIT
-9,571.3840
-9,571.3840
-23,237.4280
-1,167
-61,872.4930
EBITDA
-8,887.2270
-8,887.2270
-22,467.2780
-667
-61,872.4930
Reconciled Depreciation
684.1570
684.1570
770.1500
500
--
Net Income from Continuing Operation Net Minority Interest
-9,594
-9,594
-23,943
-1,021
-54,574.0270
Normalized EBITDA
-8,887.2270
-8,887.2270
-22,467.2780
-667
-61,872.4930
Tax Rate for Calcs
0
0
0.0002
0.0001
0.0001
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/9/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HMGN Hemagen Diagnostics, Inc.
0.0001
0.00%
 
DBP-B.ST Double Bond Pharmaceutical Int.
0.1150
-8.73%
 
ERGO Entia Biosciences, Inc.
0.0001
0.00%
 
XSPRAY.ST Xspray Pharma AB (publ)
35.50
+3.50%
 
2CUREX.ST 2cureX AB (publ)
4.4400
-2.20%
 
ISOFOL.ST Isofol Medical AB (publ)
1.0450
-8.97%
 
KAN.ST Kancera AB (publ)
1.1340
+6.58%
 
ONCO.ST Oncopeptides AB (publ)
1.4700
-3.29%
 
ACTI.ST Active Biotech AB (publ)
0.2385
-4.22%
 
LOBEF Lobe Sciences Ltd.
0.0023
-11.54%